Peterlabs Holdings Bhd (XKLS:0171) Piotroski F-Score: 5 (As of Jun. 26, 2026) — Near Median


XKLS:0171 Peterlabs Holdings Bhd XKLS:0171
47 GF Score
Price RM0.24
GF Value RM0.20
Valuation Modestly Overvalued
! 6 Warning Signs
View Full Analysis

What is Peterlabs Holdings Bhd Piotroski F-Score?

Peterlabs Holdings Bhd XKLS:0171 47 Piotroski F-Score is 5 as of Jun. 26, 2026, which is at its 10-year median of 5.00. GuruFocus rates XKLS:0171 with a GF Score™ of 47/100 and a GF Value™ of RM0.20 (Modestly Overvalued). The stock has 6 warning signs investors should review. Among 981 Drug Manufacturers companies, Peterlabs Holdings Bhd ranks better than 61.37% on this metric.

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Peterlabs Holdings Bhd has an F-score of 5 indicating the company's financial situation is typical for a stable company.

The historical rank and industry rank for Peterlabs Holdings Bhd's Piotroski F-Score or its related term are showing as below:

XKLS:0171' s Piotroski F-Score Range Over the Past 10 Years
Min: 2   Med: 5   Max: 8
Current: 5

During the past 13 years, the highest Piotroski F-Score of Peterlabs Holdings Bhd was 8. The lowest was 2. And the median was 5.

Peterlabs Holdings Bhd  (XKLS:0171) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Peterlabs Holdings Bhd Piotroski F-Score Related Terms


Peterlabs Holdings Bhd Piotroski F-Score Historical Data

* Premium members only.

The historical data trend for Peterlabs Holdings Bhd's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Peterlabs Holdings Bhd Piotroski F-Score Chart

Peterlabs Holdings Bhd Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Piotroski F-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8.00 6.00 5.00 6.00 7.00

Peterlabs Holdings Bhd Quarterly Data
Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.00 6.00 6.00 7.00 5.00

XKLS:0171 vs ZTS, UTHR, VTRS: Piotroski F-Score Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Peterlabs Holdings Bhd's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Peterlabs Holdings Bhd Piotroski F-Score vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Peterlabs Holdings Bhd's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where Peterlabs Holdings Bhd's Piotroski F-Score falls into.


XKLS:0171
47GF Score
Peterlabs Holdings Bhd XKLS:0171
Piotroski F-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Jun25) TTM:Last Year (Jun24) TTM:
Net Income was 0.767 + 0.667 + 0.763 + -1.377 = RM0.8 Mil.
Cash Flow from Operations was -1.165 + 4.949 + 0 + 0 = RM3.8 Mil.
Revenue was 41.579 + 45.369 + 33.61 + 31.764 = RM152.3 Mil.
Gross Profit was 5.575 + 5.49 + 5.544 + 0.336 = RM16.9 Mil.
Average Total Assets from the begining of this year (Jun24)
to the end of this year (Jun25) was
(120.724 + 115.118 + 120.474 + 114.06 + 112.152) / 5 = RM116.5056 Mil.
Total Assets at the begining of this year (Jun24) was RM120.7 Mil.
Long-Term Debt & Capital Lease Obligation was RM0.3 Mil.
Total Current Assets was RM67.2 Mil.
Total Current Liabilities was RM33.2 Mil.
Net Income was 1.266 + 0.737 + 0.826 + 0.583 = RM3.4 Mil.

Revenue was 46.314 + 46.287 + 46.308 + 42.775 = RM181.7 Mil.
Gross Profit was 5.641 + 5.655 + 5.808 + 5.688 = RM22.8 Mil.
Average Total Assets from the begining of last year (Jun23)
to the end of last year (Jun24) was
(109.152 + 114.35 + 118.395 + 117.96 + 120.724) / 5 = RM116.1162 Mil.
Total Assets at the begining of last year (Jun23) was RM109.2 Mil.
Long-Term Debt & Capital Lease Obligation was RM2.3 Mil.
Total Current Assets was RM84.3 Mil.
Total Current Liabilities was RM36.5 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Peterlabs Holdings Bhd's current Net Income (TTM) was 0.8. ==> Positive ==> Score 1.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Peterlabs Holdings Bhd's current Cash Flow from Operations (TTM) was 3.8. ==> Positive ==> Score 1.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Jun24)
=0.82/120.724
=0.00679235

ROA (Last Year)=Net Income/Total Assets (Jun23)
=3.412/109.152
=0.03125916

Peterlabs Holdings Bhd's return on assets of this year was 0.00679235. Peterlabs Holdings Bhd's return on assets of last year was 0.03125916. ==> Last year is higher ==> Score 0.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Peterlabs Holdings Bhd's current Net Income (TTM) was 0.8. Peterlabs Holdings Bhd's current Cash Flow from Operations (TTM) was 3.8. ==> 3.8 > 0.8 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Jun25)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Jun24 to Jun25
=0.344/116.5056
=0.00295265

Gearing (Last Year: Jun24)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Jun23 to Jun24
=2.253/116.1162
=0.01940298

Peterlabs Holdings Bhd's gearing of this year was 0.00295265. Peterlabs Holdings Bhd's gearing of last year was 0.01940298. ==> This year is lower or equal to last year. ==> Score 1.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Jun25)=Total Current Assets/Total Current Liabilities
=67.159/33.199
=2.02292238

Current Ratio (Last Year: Jun24)=Total Current Assets/Total Current Liabilities
=84.271/36.487
=2.30961712

Peterlabs Holdings Bhd's current ratio of this year was 2.02292238. Peterlabs Holdings Bhd's current ratio of last year was 2.30961712. ==> Last year's current ratio is higher ==> Score 0.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Peterlabs Holdings Bhd's number of shares in issue this year was 275.214. Peterlabs Holdings Bhd's number of shares in issue last year was 275.214. ==> There is smaller number of shares in issue this year, or the same. ==> Score 1.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=16.945/152.322
=0.1112446

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=22.792/181.684
=0.12544858

Peterlabs Holdings Bhd's gross margin of this year was 0.1112446. Peterlabs Holdings Bhd's gross margin of last year was 0.12544858. ==> Last year's gross margin is higher ==> Score 0.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Jun24)
=152.322/120.724
=1.26173752

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Jun23)
=181.684/109.152
=1.66450454

Peterlabs Holdings Bhd's asset turnover of this year was 1.26173752. Peterlabs Holdings Bhd's asset turnover of last year was 1.66450454. ==> Last year's asset turnover is higher ==> Score 0.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=1+1+0+1+1+0+1+0+0
=5

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Peterlabs Holdings Bhd has an F-score of 5 indicating the company's financial situation is typical for a stable company.

Frequently Asked Questions Learn more about Piotroski F-Score →
What does a Piotroski F-Score of 5 mean?
Peterlabs Holdings Bhd (XKLS:0171) has a Piotroski F-Score of 5 as of Jun. 26, 2026. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Peterlabs Holdings Bhd and its competitors. This is near median its historical median of 5.00. Over the past decade, Peterlabs Holdings Bhd's Piotroski F-Score has ranged from 2.00 to 8.00. According to the industry distribution chart, Peterlabs Holdings Bhd ranks #379 out of 981 companies in the Drug Manufacturers industry, placing it in the top 38.6%.
Is Peterlabs Holdings Bhd's Piotroski F-Score too high?
Peterlabs Holdings Bhd's current Piotroski F-Score of 5 is near median its 10-year median of 5.00. Over the past 10 years, this metric has ranged from a low of 2.00 to a high of 8.00. The Drug Manufacturers industry median Piotroski F-Score is 5.00. Peterlabs Holdings Bhd's value of 5 is 0% at this industry median. Based on the distribution chart, Peterlabs Holdings Bhd ranks #379 out of 981 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Peterlabs Holdings Bhd has a GF Score™ of 47/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Peterlabs Holdings Bhd's Piotroski F-Score compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Peterlabs Holdings Bhd ranks #379 out of 981 companies for Piotroski F-Score. This puts Peterlabs Holdings Bhd in the upper half of its industry. The industry median Piotroski F-Score is 5.00. Peterlabs Holdings Bhd's value of 5 is 0% at this benchmark. Historically, Peterlabs Holdings Bhd's own Piotroski F-Score has ranged from 2.00 to 8.00 over the past decade. While the company's 10-year median is 5.00 vs. the industry median of 5.00, Peterlabs Holdings Bhd has consistently been at the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Piotroski F-Score for a Drug Manufacturers company?
The median Piotroski F-Score among Drug Manufacturers companies is 5.00, based on 981 companies in the industry. Companies in the top quartile (top 25%) have a Piotroski F-Score significantly above this median, while those in the bottom quartile fall well below. However, Piotroski F-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Peterlabs Holdings Bhd's current Piotroski F-Score of 5 is 0% at the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Piotroski F-Score mean?
A high Piotroski F-Score can signal that a stock is expensive relative to its fundamentals. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Peterlabs Holdings Bhd and its competitors. For the Drug Manufacturers industry, the median Piotroski F-Score is 5.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Peterlabs Holdings Bhd's current Piotroski F-Score is 5, which is near median its own 10-year median of 5.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Peterlabs Holdings Bhd stock overvalued right now?
Based on GuruFocus' analysis, Peterlabs Holdings Bhd (XKLS:0171) is currently considered Modestly Overvalued. The stock's GF Value™ is RM0.20, compared to a current price of RM0.24 — trading 17.5% above its estimated fair value. The current Piotroski F-Score is 5, which is near median its 10-year median of 5.00 and 0% at the Drug Manufacturers industry median of 5.00. Peterlabs Holdings Bhd's overall GF Score™ is 47/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Piotroski F-Score calculated?
Piotroski F-Score is calculated from a company's financial statements. For Peterlabs Holdings Bhd (XKLS:0171), the current Piotroski F-Score is 5 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Peterlabs Holdings Bhd (XKLS:0171) Overvalued in 2026?

Based on GuruFocus' analysis, Peterlabs Holdings Bhd stock appears to be overvalued. The current stock price of RM0.24 is trading 17.5% above its estimated GF Value™ of RM0.20. GuruFocus considers Peterlabs Holdings Bhd to be Modestly Overvalued.

Key valuation signals for XKLS:0171:

  • Piotroski F-Score: 5 (near median its 10-year median of 5.00)
  • GF Value™: RM0.20 vs. price of RM0.24 (17.5% above fair value)
  • GF Score™: 47/100 with 6 warning signs
  • Industry Position: 0% at the Drug Manufacturers median (#379 of 981)

No single metric tells the full story. See the XKLS:0171 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Peterlabs Holdings Bhd Business Description

Address Jalan Nilam 3, Lot 16014 (PT No. 24341), Bandar Nilai Utama, Nilai, NSN, MYS, 71800
Peterlabs Holdings Bhd is engaged in the manufacturing, distribution, export, and trading of animal health and nutrition products. The Group offers biosecurity and disinfectants, compound feed supplements, feed additives, nutritional premixes, pharmaceuticals, and water-soluble supplements, as well as farm management, technical advisory services, raw material analysis, and feed formulation. Its segments are Manufacturing, which covers the manufacturing and distribution of animal health and nutrition products; Trading, which involves the trading and distribution of animal health and nutrition products and consumer goods, and contributes the majority of its revenue; and Others, which provides investment holding services. The company operates in Malaysia and internationally.
47GF Score

Get the complete analysis for XKLS:0171

Piotroski F-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

RM0.24
Price
RM0.20
GF Value